Glioma therapies: How to tell which work?

Journal of Clinical Oncology

Volumn 21, Issue 19, 2003, Pages 3547-3549

  Perry, James R ^a   Cairncross, J Gregory ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMATINIB; LOMUSTINE; PACLITAXEL; PROCARBAZINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; GLIOBLASTOMA; GLIOMA; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; BIOASSAY; BRAIN TUMOR; NOTE; RADIOGRAPHY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN NEOPLASMS; ENDPOINT DETERMINATION; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0141904698     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.05.885     Document Type: Editorial

References (10)

1. Macdonald DR, Cascino TL, Schold SC Jr, et al: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280, 1990
2. Cairncross JG, Pexman JHW, Rathbone MP, et al: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17:570-572, 1985
3. Forsyth PAJ, Petrov E, Mahallati H, et al: Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 15:2076-2081, 1997
4. Vos MJ, Uitdehaag BMJ, Barkhof F, et al: Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology 60:826-830, 2003
5. Perry JR, DeAngelis LM, Schold SC Jr et al: Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology 49:912-917, 1997
6. Mardor Y, Pfeffer R, Spiegelmann R, et al: Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 21:1094-1100, 2003
7. Vos MJ, Hoekstra OS, Barkhof F, et al: Thallium-201 single-photon emission computed tomography as early predictor of outcome in recurrent glioma. J Clin Oncol 21:3559-3565, 2003
8. Betensky RA, Louis DN, Cairncross JG: Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol 20:2495-2499, 2002
9. Eisenhauer EA: Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy, and existentialism. Ann Oncol 8:1047-1052, 1998
10. Lang FF, Gilbert MR, Puduvalli VK, et al: Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies. Neuro-oncol 4:268-277, 2002